Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines fo... von Kyle, R A, Durie, B G M, Rajkumar, S V, Landgren, O, Blade, J, Merlini, G, Kröger, N, Einsele, H, Vesole, D H, Dimopoulos, M, San Miguel, J, Avet-Loiseau, H, Hajek, R, Chen, W M, Anderson, K C, Ludwig, H, Sonneveld, P, Pavlovsky, S, Palumbo, A, Richardson, P G, Barlogie, B, Greipp, P, Vescio, R, Turesson, I, Westin, J, Boccadoro, M

Volltext

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma von Dimopoulos, M, Terpos, E, Comenzo, R L, Tosi, P, Beksac, M, Sezer, O, Siegel, D, Lokhorst, H, Kumar, S, Rajkumar, S V, Niesvizky, R, Moulopoulos, L A, Durie, B G M

Volltext

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma von Larsen, J T, Kumar, S K, Dispenzieri, A, Kyle, R A, Katzmann, J A, Rajkumar, S V

Volltext

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma von Rajkumar, S V, Gupta, V, Fonseca, R, Dispenzieri, A, Gonsalves, W I, Larson, D, Ketterling, R P, Lust, J A, Kyle, R A, Kumar, S K

Volltext

International uniform response criteria for multiple myeloma von DURIE, B. G. M, HAROUSSEAU, J.-L, LUDWIG, H, GAHRTON, G, BEKSAC, M, CROWLEY, J, BELCH, A, BOCCADARO, M, TURESSON, I, JOSHUA, D, VESOLE, D, KYLE, R, MIGUEL, J. S, ALEXANIAN, R, TRICOT, G, ATTAL, M, MERLINI, G, POWLES, R, RICHARDSON, P, SHIMIZU, K, TOSI, P, MORGAN, G, RAJKUMAR, S. V, BLADE, J, BARLOGIE, B, ANDERSON, K, GERTZ, M, DIMOPOULOS, M, WESTIN, J, SONNEVELD, P

Volltext

N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression von Dispenzieri, Angela, Larson, D. R., Rajkumar, S. V., Kyle, R. A., Kumar, S. K., Kourelis, Taxiarchis, Arendt, Bonnie, Willrcih, Maria, Dasari, Surendra, Murray, David

Volltext

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders von Dispenzieri, A, Kyle, R, Merlini, G, Miguel, J S, Ludwig, H, Hajek, R, Palumbo, A, Jagannath, S, Blade, J, Lonial, S, Dimopoulos, M, Comenzo, R, Einsele, H, Barlogie, B, Anderson, K, Gertz, M, Harousseau, J L, Attal, M, Tosi, P, Sonneveld, P, Boccadoro, M, Morgan, G, Richardson, P, Sezer, O, Mateos, M V, Cavo, M, Joshua, D, Turesson, I, Chen, W, Shimizu, K, Powles, R, Rajkumar, S V, Durie, B G M

Volltext

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents von Majithia, N, Rajkumar, S V, Lacy, M Q, Buadi, F K, Dispenzieri, A, Gertz, M A, Hayman, S R, Dingli, D, Kapoor, P, Hwa, L, Lust, J A, Russell, S J, Go, R S, Kyle, R A, Kumar, S K

Volltext

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma von Short, K Detweiler, Rajkumar, S V, Larson, D, Buadi, F, Hayman, S, Dispenzieri, A, Gertz, M, Kumar, S, Mikhael, J, Roy, V, Kyle, R A, Lacy, M Q

Volltext

Genetic aberrations and survival in plasma cell leukemia von Tiedemann, R E, Gonzalez-Paz, N, Kyle, R A, Santana-Davila, R, Price-Troska, T, Van Wier, S A, Chng, W J, Ketterling, R P, Gertz, M A, Henderson, K, Greipp, P R, Dispenzieri, A, Lacy, M Q, Rajkumar, S V, Bergsagel, P L, Stewart, A K, Fonseca, R

Volltext

Treatment of newly diagnosed myeloma von Palumbo, A, Rajkumar, S V

Volltext

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma von Gonsalves, W I, Rajkumar, S V, Gupta, V, Morice, W G, Timm, M M, Singh, P P, Dispenzieri, A, Buadi, F K, Lacy, M Q, Kapoor, P, Gertz, M A, Kumar, S K

Volltext

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma von Bianchi, G, Kyle, R A, Larson, D R, Witzig, T E, Kumar, S, Dispenzieri, A, Morice, W G, Rajkumar, S V

Volltext

Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites von Greenberg, A J, Vachon, C M, Rajkumar, S V

Volltext

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM) von Lacy, M Q, Hayman, S R, Gertz, M A, Short, K D, Dispenzieri, A, Kumar, S, Greipp, P R, Lust, J A, Russell, S J, Dingli, D, Zeldenrust, S, Fonseca, R, Bergsagel, P L, Roy, V, Mikhael, J R, Stewart, A K, Laumann, K, Allred, J B, Mandrekar, S J, Rajkumar, S V, Buadi, F

Volltext

Clinically relevant end points and new drug approvals for myeloma von Anderson, K C, Kyle, R A, Rajkumar, S V, Stewart, A K, Weber, D, Richardson, P

Volltext

Management of treatment-emergent peripheral neuropathy in multiple myeloma von Richardson, P G, Delforge, M, Beksac, M, Wen, P, Jongen, J L, Sezer, O, Terpos, E, Munshi, N, Palumbo, A, Rajkumar, S V, Harousseau, J L, Moreau, P, Avet-Loiseau, H, Lee, J H, Cavo, M, Merlini, G, Voorhees, P, Chng, W J, Mazumder, A, Usmani, S, Einsele, H, Comenzo, R, Orlowski, R, Vesole, D, Lahuerta, J J, Niesvizky, R, Siegel, D, Mateos, M-V, Dimopoulos, M, Lonial, S, Jagannath, S, Bladé, J, Miguel, J San, Morgan, G, Anderson, K C, Durie, B G M, Sonneveld, P

Volltext

Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design von Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Kapoor, P., Grogan, M., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.

Volltext

Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design von Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Kapoor, P., Grogan, M., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., Rajkumar, S. V., Gertz, M. A., Dispenzieri, A.

Volltext

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project von Avet-Loiseau, H, Durie, B G M, Cavo, M, Attal, M, Gutierrez, N, Haessler, J, Goldschmidt, H, Hajek, R, Lee, J H, Sezer, O, Barlogie, B, Crowley, J, Fonseca, R, Testoni, N, Ross, F, Rajkumar, S V, Sonneveld, P, Lahuerta, J, Moreau, P, Morgan, G

Volltext